Innate immune responses to viral infections.

D. Woodland

DOI: https://doi.org/10.1089/vim.2014.1501

2014-05-14

Viral Immunology

Abstract:The capacity of viruses to invade cells and harness cellular metabolism for replication poses a unique problem for the host—to identify rapidly cells that are virally infected. This facet has driven the evolution of innate cellular mechanisms that specifically detect virus infection in the cell and restrict viral replication. The critical role of innate immunity to virus infections has been a major focus of recent research, and the current issue of Viral Immunology highlights recent advances in this area. Tasker et al. have uncovered a previously unappreciated innate role for estrogen in the control of human immunodeficiency virus (HIV) infection. Previous studies had indicated that estrogen exhibits a protective effect against HIV transmission, possibly through mechanical mechanisms, such as increasing the thickness of genital epithelium. The authors now show that macrophages are the main target for the anti-HIV effect of 17b-estradiol (E2). This effect was not due to modulation of the surface expression of CD4 or HIV co-receptors or HIV attachment to monocytederived macrophages. Instead, E2 blocked HIV reverse transcription by inducing gene expression of type I interferons and myeloid cell-specific host restriction factor APOBEC3A, thereby inducing an antiviral state. These studies highlight the interplay between HIV and E2-mediated innate immune responses, and offer new insights for the development of effective strategies to block HIV infection. The innate response to viral infections can also be triggered by Toll-like receptors (TLRs) that are able to recognize and trigger host responses to viral components specifically. Two reports by St. Paul et al. describe how TLR ligands can be used as adjuvants for avian influenza A virus vaccines. The authors assessed the adjuvant potential of TLR ligands Pam3 (TLR-2), poly I:C (TLR-3), lipopolysaccharide (TLR-4), flagellin (TLR-5), and CPG DNA motifs (TLR-9) in the context of an inactivated H4N6 influenza vaccine in chickens. The results suggest that several of the adjuvants increased antibody responses although to different degrees. The authors further note that chickens receiving vaccines containing either flagellin or Pam3 adjuvants were partially protected from an experimental influenza virus challenge and shed significantly less virus compared to controls. In another study of innate immunity, Valero et al. investigate the induction of cytokines by monocytes and macrophages infected with dengue virus from individuals of different ages. Increased production of TNF-a, IL-6, and IL1b was induced in monocyte/macrophage cultures regardless of age. However, lower cytokine concentrations were found in neonatal and elderly monocytes. The authors suggest that the moderately immunosuppressed status observed in neonates and elderly individuals could be relevant during dengue infection, and may be important in innate and adaptive immune responses against this virus. Two articles in this issue of Viral Immunology address technical issues. Ovsyannikova et al. compared the use of turkey or guinea pig red blood cells (RBCs) in influenza hemagglutination inhibition assays to determine antibody titers to pandemic influenza virus A/H1N1. The authors demonstrate that turkey RBCs appear to be the more appropriate choice for these assays. Lu et al. developed a gating strategy for determining CD4 + recent thymic emigrants (RTEs) in human immunodeficiency virus-1 (HIV-1) infected patients (alterations in RTE frequencies in the blood are associated with HIV-1 disease progression following antiretroviral therapy). An important feature of the gating strategy is the inclusion of markers such as CCR7 that better distinguish CD4 + RTE subset in HIV-1 + subjects. Finally, I would like to thank all of the authors for their excellent contributions to the journal.